B dot Medical to Install Ultra-compact Proton Therapy System at Thammasat University in Thailand

- Responding to Growing Needs for Urban-type Proton Therapy in Thailand -

TOKYO and BANGKOK,Feb. 13,2023 --B dot Medical Inc. and Thammasat University,a leading national university inThailand,have signed a memorandum of understanding to install theultra-compact proton therapy system developed by B dot Medical. The agreementencourages installing the advanced cancer treatment system in Thailand,wherethe population profile is aging at the fastest pace among major ASEANcountries. The agreement provides B dot Medical an opportunity to expand protontherapy further in the global market.

Logos:

https://kyodonewsprwire.jp/prwfile/release/M105528/202302072729/_prw_PI5fl_8gH8o1u5.jpg

Photo: Associate Prof. Gasinee Witoonchart,Thammasat University (second fromright) and Takuji Furukawa,B dot Medical (furthest to right)

https://kyodonewsprwire.jp/prwfile/release/M105528/202302072729/_prw_PI3fl_14A1bZIu.jpg

The memorandum of understanding was realized through a sales alliance with OlbaHealthcare Holdings,Inc.,a leading medical device distributor in Japan. OlbaHealthcare established a subsidiary in Thailand,THAI OLBA Healthcare Co.,Ltd.,in 2023 in anticipation of the growing healthcare industry in thatregion. They will provide strong partnership for the business development of Bdot Medical in Thailand and the ASEAN region.

In recent years,countries in Southeast Asia experienced population growth,accompanied by rising GDP and national incomes,leading to calls for moreadvanced medical care to be made available. In Thailand,in particular,thecountry's social security system reforms since 2000 have changed its medicalenvironment,and at the same time,economic growth has led to a sharp increasein the number of cancer patients,and the need for advanced cancer treatment,such as proton therapy.

However,the space needed for a conventional large-scale proton therapy system is an issue due to the high population density of Bangkok,as approximately 1/5of the country's total population is concentrated in that area. Therefore,there is only one facility for proton therapy in Thailand as of 2023. B dotMedical's ultra-compact proton therapy system,one of the smallest in theworld,is suitable for placement in such urban areas. This breakthroughprompted Thammasat University to go forward with proton therapy.

Thammasat University will be celebrating its 90th anniversary in 2024. A newhospital ward in the university is planned to mark the milestone,with thetherapy project also highlighted. The clinical trial required for the sale of aproton therapy system in Thailand will be led by Thammasat University. Thethree-party collaboration will allow the partners to work closely together forthe success of the project,marking this as the starting point for theadvancement of proton therapy in the global market.

Comment from Associate Prof. Gasinee Witoonchart,Rector of ThammasatUniversity:

"Thammasat University has continued creating social innovation in alldimensions for the people and the future. As the economic development of recentyears has caused an increase in the number of cancer patients,we are proud tobring this groundbreaking proton therapy system and look forward to providingpeople with advanced medical treatment."

Comment from Yohei Maeshima,President and CEO of Olba Healthcare:

"We position Thailand as the medical hub in the ASEAN region where thepopulation is aging,and a point of development for our business in the ASEANcountries. Through the introduction of proton therapy,we aim to contribute tothe healthy life span of the people and to become the bridge between Thailandand Japan in the medical field."

Comment from Takuji Furukawa,President and CEO of B dot Medical:

"The signing of this MOU is the first step toward global expansion for us,andsignifies that B dot Medical's work is being recognized around the world. Welook forward to working with Thammasat University on this innovative project tobring the advanced world-class cancer treatment to ASEAN countries,includingThailand."

For more details about proton therapy,please visit:

https://kyodonewsprwire.jp/attach/202302072729-O5-I68YRBu3.pdf

About Thammasat University

https://kyodonewsprwire.jp/attach/202302072729-O3-6C64H7Z1.pdf

About Olba Healthcare Holdings,Inc.

https://kyodonewsprwire.jp/attach/202302072729-O4-4tn51Y25.pdf

About B dot Medical Inc.

B dot Medical is a startup company originating from the National Institute ofRadiological Sciences (NIRS). The company has developed the "ultra-compactproton therapy system" utilizing the advanced technology and experience gainedat NIRS. The company is challenging the world with Japanese technologicalinnovation.

Name: B dot Medical Inc.

Address: 5-10-10 Harue-cho,Edogawa-ku,Tokyo 134-0003 JAPAN

Representative: Takuji Furukawa,President and CEO

Founded: March 1,2017

Business activity:

Developing proton therapy systems

Consulting support for particle therapy

B dot Medical's official website: https://bdotmed.co.jp/en/

View original content:https://www.prnewswire.com/news-releases/b-dot-medical-to-install-ultra-compact-proton-therapy-system-at-thammasat-university-in-thailand-301744825.html